Clinical Trial: A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery System Products

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739797) titled 'A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery System Products' on July 28.

Brief Summary: This will be a randomized, open-label, 8-way crossover, single-site study designed to evaluate elements of abuse liability (AL), including subjective effects and physiological measures (pharmacodynamics [PD]), and plasma nicotine uptake (pharmacokinetics [PK]) during and following ad libitum use of electronic nicotine delivery system (ENDS) investigational products (IPs). The study will be conducted in a confinement setting among generally healthy adult smokers of combustible cigarettes and dual users of cigarettes and ENDS...